Reunion Neuroscience Inc
Clinical trials sponsored by Reunion Neuroscience Inc, explained in plain language.
-
Single shot could lift postpartum depression, early trial hints
Symptom relief CompletedThis study tested a single injection of RE104 in 84 women with moderate-to-severe postpartum depression. The goal was to see if it reduces depressive symptoms better than a low-dose comparison. Results will help determine if this approach is safe and effective for new mothers.
Phase: PHASE2 • Sponsor: Reunion Neuroscience Inc • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Tiny dose, big data: healthy volunteers help map RE104's journey through the body
Knowledge-focused CompletedThis study looked at how a single tiny dose of RE104 moves through and leaves the body in 8 healthy adults. Researchers measured the drug and its breakdown products in blood, urine, and stool over at least a week. The goal was purely to understand absorption and elimination, not …
Phase: PHASE1 • Sponsor: Reunion Neuroscience Inc • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC